Sale!

KCNA1 Gene Episodic Ataxia Type 1 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The KCNA1 Gene Episodic Ataxia Type 1 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the KCNA1 gene responsible for episodic ataxia type 1, a rare neurological disorder characterized by recurrent episodes of poor coordination and balance. Using next-generation sequencing technology, this test provides comprehensive analysis of the KCNA1 gene to detect pathogenic variants that disrupt potassium channel function in nerve cells. The test is particularly valuable for individuals experiencing sudden attacks of ataxia, tremors, or muscle twitching, as well as those with a family history of similar symptoms. Results typically take 3-4 weeks and require a simple blood sample or extracted DNA. At only $500, this test offers crucial insights for accurate diagnosis, treatment planning, and genetic counseling.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

KCNA1 Gene Episodic Ataxia Type 1 NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The KCNA1 Gene Episodic Ataxia Type 1 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations responsible for episodic ataxia type 1. This rare inherited condition affects the nervous system’s ability to maintain proper coordination and movement control. Our advanced testing methodology provides patients and healthcare providers with definitive answers for accurate diagnosis and personalized treatment approaches.

What This Test Measures and Detects

This specialized genetic test utilizes next-generation sequencing (NGS) technology to comprehensively analyze the KCNA1 gene, which encodes voltage-gated potassium channels essential for proper nerve cell function. The test specifically identifies:

  • Pathogenic variants in the KCNA1 gene that disrupt potassium channel activity
  • Missense mutations affecting channel gating and kinetics
  • Deletions or insertions that alter protein structure
  • Single nucleotide polymorphisms associated with episodic ataxia type 1
  • Inheritance patterns through family genetic analysis

Who Should Consider This Test

This genetic test is recommended for individuals experiencing symptoms suggestive of episodic ataxia type 1 or those with a family history of neurological disorders. Key indications include:

  • Recurrent episodes of poor coordination and balance difficulties
  • Sudden attacks of unsteady gait or stumbling
  • Intermittent tremors or muscle twitching
  • Family history of similar neurological symptoms
  • Unexplained episodes of dizziness or vertigo
  • Children or adults with suspected inherited movement disorders
  • Patients with negative results from standard neurological evaluations

Benefits of Genetic Testing

Undergoing the KCNA1 Gene Episodic Ataxia Type 1 test provides numerous advantages for patients and their families:

  • Accurate Diagnosis: Confirms or rules out episodic ataxia type 1 with high precision
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates timely management strategies to improve quality of life
  • Peace of Mind: Reduces uncertainty and provides clarity about neurological symptoms
  • Research Contribution: Helps advance understanding of rare neurological conditions

Understanding Your Test Results

Our comprehensive genetic counseling services help patients interpret their results effectively:

  • Positive Result: Indicates the presence of a pathogenic KCNA1 gene mutation associated with episodic ataxia type 1. This confirms the diagnosis and enables targeted treatment planning.
  • Negative Result: Suggests that no known pathogenic variants were detected in the KCNA1 gene, though other genetic or non-genetic causes should still be considered.
  • Variant of Uncertain Significance: Some genetic changes may have unknown clinical implications, requiring further evaluation and monitoring.
  • Carrier Status: Identifies individuals who carry the mutation but may not show symptoms, important for family planning decisions.

Test Pricing and Details

Test Feature Details
Test Name KCNA1 Gene Episodic Ataxia Type 1 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We have diagnostic centers conveniently located throughout the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified genetic counselors and neurological specialists ensures comprehensive care regardless of your location.

Take Control of Your Neurological Health Today

Don’t let uncertainty about neurological symptoms affect your quality of life. Our KCNA1 Gene Episodic Ataxia Type 1 NGS Genetic DNA Test provides the clarity you need for proper diagnosis and treatment. With our discounted price of only $500 and comprehensive genetic counseling services, you can make informed decisions about your health and future.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward understanding your neurological health.